The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cancer Screening Tests Market Research Report 2024
Synopsis
The global Cancer Screening Tests market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cancer Screening Tests is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cancer Screening Tests is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cancer Screening Tests in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cancer Screening Tests include Hologic, Siemens, GRAIL, Carestream Health, Philips, Shimadzu, Canon Medical Systems, Hitachi and Esaote, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Screening Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Screening Tests.
Report Scope
The Cancer Screening Tests market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Screening Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Screening Tests companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hologic
Siemens
GRAIL
Carestream Health
Philips
Shimadzu
Canon Medical Systems
Hitachi
Esaote
Agilent Technologies
Abbott
Beckman Coulter
QIAGEN
R-Biopharm
Sysmex
Thrive Early Early Detection
Guardant Health
Segment by Type
Physical Exam
Imaging Tests
Genetic Tests
Other
Segment by Application
Hospital
Clinic
Lab
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Screening Tests companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Cancer Screening Tests market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cancer Screening Tests is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cancer Screening Tests is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cancer Screening Tests in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cancer Screening Tests include Hologic, Siemens, GRAIL, Carestream Health, Philips, Shimadzu, Canon Medical Systems, Hitachi and Esaote, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Screening Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Screening Tests.
Report Scope
The Cancer Screening Tests market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Screening Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Screening Tests companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hologic
Siemens
GRAIL
Carestream Health
Philips
Shimadzu
Canon Medical Systems
Hitachi
Esaote
Agilent Technologies
Abbott
Beckman Coulter
QIAGEN
R-Biopharm
Sysmex
Thrive Early Early Detection
Guardant Health
Segment by Type
Physical Exam
Imaging Tests
Genetic Tests
Other
Segment by Application
Hospital
Clinic
Lab
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Screening Tests companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Screening Tests Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Physical Exam
1.2.3 Imaging Tests
1.2.4 Genetic Tests
1.2.5 Other
1.3 Market by Application
1.3.1 Global Cancer Screening Tests Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Lab
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Screening Tests Market Perspective (2019-2030)
2.2 Cancer Screening Tests Growth Trends by Region
2.2.1 Global Cancer Screening Tests Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cancer Screening Tests Historic Market Size by Region (2019-2024)
2.2.3 Cancer Screening Tests Forecasted Market Size by Region (2025-2030)
2.3 Cancer Screening Tests Market Dynamics
2.3.1 Cancer Screening Tests Industry Trends
2.3.2 Cancer Screening Tests Market Drivers
2.3.3 Cancer Screening Tests Market Challenges
2.3.4 Cancer Screening Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Screening Tests Players by Revenue
3.1.1 Global Top Cancer Screening Tests Players by Revenue (2019-2024)
3.1.2 Global Cancer Screening Tests Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Screening Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Screening Tests Revenue
3.4 Global Cancer Screening Tests Market Concentration Ratio
3.4.1 Global Cancer Screening Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Screening Tests Revenue in 2023
3.5 Cancer Screening Tests Key Players Head office and Area Served
3.6 Key Players Cancer Screening Tests Product Solution and Service
3.7 Date of Enter into Cancer Screening Tests Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Screening Tests Breakdown Data by Type
4.1 Global Cancer Screening Tests Historic Market Size by Type (2019-2024)
4.2 Global Cancer Screening Tests Forecasted Market Size by Type (2025-2030)
5 Cancer Screening Tests Breakdown Data by Application
5.1 Global Cancer Screening Tests Historic Market Size by Application (2019-2024)
5.2 Global Cancer Screening Tests Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cancer Screening Tests Market Size (2019-2030)
6.2 North America Cancer Screening Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cancer Screening Tests Market Size by Country (2019-2024)
6.4 North America Cancer Screening Tests Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Screening Tests Market Size (2019-2030)
7.2 Europe Cancer Screening Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cancer Screening Tests Market Size by Country (2019-2024)
7.4 Europe Cancer Screening Tests Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Screening Tests Market Size (2019-2030)
8.2 Asia-Pacific Cancer Screening Tests Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cancer Screening Tests Market Size by Region (2019-2024)
8.4 Asia-Pacific Cancer Screening Tests Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Screening Tests Market Size (2019-2030)
9.2 Latin America Cancer Screening Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cancer Screening Tests Market Size by Country (2019-2024)
9.4 Latin America Cancer Screening Tests Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Screening Tests Market Size (2019-2030)
10.2 Middle East & Africa Cancer Screening Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cancer Screening Tests Market Size by Country (2019-2024)
10.4 Middle East & Africa Cancer Screening Tests Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hologic
11.1.1 Hologic Company Detail
11.1.2 Hologic Business Overview
11.1.3 Hologic Cancer Screening Tests Introduction
11.1.4 Hologic Revenue in Cancer Screening Tests Business (2019-2024)
11.1.5 Hologic Recent Development
11.2 Siemens
11.2.1 Siemens Company Detail
11.2.2 Siemens Business Overview
11.2.3 Siemens Cancer Screening Tests Introduction
11.2.4 Siemens Revenue in Cancer Screening Tests Business (2019-2024)
11.2.5 Siemens Recent Development
11.3 GRAIL
11.3.1 GRAIL Company Detail
11.3.2 GRAIL Business Overview
11.3.3 GRAIL Cancer Screening Tests Introduction
11.3.4 GRAIL Revenue in Cancer Screening Tests Business (2019-2024)
11.3.5 GRAIL Recent Development
11.4 Carestream Health
11.4.1 Carestream Health Company Detail
11.4.2 Carestream Health Business Overview
11.4.3 Carestream Health Cancer Screening Tests Introduction
11.4.4 Carestream Health Revenue in Cancer Screening Tests Business (2019-2024)
11.4.5 Carestream Health Recent Development
11.5 Philips
11.5.1 Philips Company Detail
11.5.2 Philips Business Overview
11.5.3 Philips Cancer Screening Tests Introduction
11.5.4 Philips Revenue in Cancer Screening Tests Business (2019-2024)
11.5.5 Philips Recent Development
11.6 Shimadzu
11.6.1 Shimadzu Company Detail
11.6.2 Shimadzu Business Overview
11.6.3 Shimadzu Cancer Screening Tests Introduction
11.6.4 Shimadzu Revenue in Cancer Screening Tests Business (2019-2024)
11.6.5 Shimadzu Recent Development
11.7 Canon Medical Systems
11.7.1 Canon Medical Systems Company Detail
11.7.2 Canon Medical Systems Business Overview
11.7.3 Canon Medical Systems Cancer Screening Tests Introduction
11.7.4 Canon Medical Systems Revenue in Cancer Screening Tests Business (2019-2024)
11.7.5 Canon Medical Systems Recent Development
11.8 Hitachi
11.8.1 Hitachi Company Detail
11.8.2 Hitachi Business Overview
11.8.3 Hitachi Cancer Screening Tests Introduction
11.8.4 Hitachi Revenue in Cancer Screening Tests Business (2019-2024)
11.8.5 Hitachi Recent Development
11.9 Esaote
11.9.1 Esaote Company Detail
11.9.2 Esaote Business Overview
11.9.3 Esaote Cancer Screening Tests Introduction
11.9.4 Esaote Revenue in Cancer Screening Tests Business (2019-2024)
11.9.5 Esaote Recent Development
11.10 Agilent Technologies
11.10.1 Agilent Technologies Company Detail
11.10.2 Agilent Technologies Business Overview
11.10.3 Agilent Technologies Cancer Screening Tests Introduction
11.10.4 Agilent Technologies Revenue in Cancer Screening Tests Business (2019-2024)
11.10.5 Agilent Technologies Recent Development
11.11 Abbott
11.11.1 Abbott Company Detail
11.11.2 Abbott Business Overview
11.11.3 Abbott Cancer Screening Tests Introduction
11.11.4 Abbott Revenue in Cancer Screening Tests Business (2019-2024)
11.11.5 Abbott Recent Development
11.12 Beckman Coulter
11.12.1 Beckman Coulter Company Detail
11.12.2 Beckman Coulter Business Overview
11.12.3 Beckman Coulter Cancer Screening Tests Introduction
11.12.4 Beckman Coulter Revenue in Cancer Screening Tests Business (2019-2024)
11.12.5 Beckman Coulter Recent Development
11.13 QIAGEN
11.13.1 QIAGEN Company Detail
11.13.2 QIAGEN Business Overview
11.13.3 QIAGEN Cancer Screening Tests Introduction
11.13.4 QIAGEN Revenue in Cancer Screening Tests Business (2019-2024)
11.13.5 QIAGEN Recent Development
11.14 R-Biopharm
11.14.1 R-Biopharm Company Detail
11.14.2 R-Biopharm Business Overview
11.14.3 R-Biopharm Cancer Screening Tests Introduction
11.14.4 R-Biopharm Revenue in Cancer Screening Tests Business (2019-2024)
11.14.5 R-Biopharm Recent Development
11.15 Sysmex
11.15.1 Sysmex Company Detail
11.15.2 Sysmex Business Overview
11.15.3 Sysmex Cancer Screening Tests Introduction
11.15.4 Sysmex Revenue in Cancer Screening Tests Business (2019-2024)
11.15.5 Sysmex Recent Development
11.16 Thrive Early Early Detection
11.16.1 Thrive Early Early Detection Company Detail
11.16.2 Thrive Early Early Detection Business Overview
11.16.3 Thrive Early Early Detection Cancer Screening Tests Introduction
11.16.4 Thrive Early Early Detection Revenue in Cancer Screening Tests Business (2019-2024)
11.16.5 Thrive Early Early Detection Recent Development
11.17 Guardant Health
11.17.1 Guardant Health Company Detail
11.17.2 Guardant Health Business Overview
11.17.3 Guardant Health Cancer Screening Tests Introduction
11.17.4 Guardant Health Revenue in Cancer Screening Tests Business (2019-2024)
11.17.5 Guardant Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Cancer Screening Tests Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Physical Exam
Table 3. Key Players of Imaging Tests
Table 4. Key Players of Genetic Tests
Table 5. Key Players of Other
Table 6. Global Cancer Screening Tests Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Cancer Screening Tests Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Cancer Screening Tests Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Cancer Screening Tests Market Share by Region (2019-2024)
Table 10. Global Cancer Screening Tests Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Cancer Screening Tests Market Share by Region (2025-2030)
Table 12. Cancer Screening Tests Market Trends
Table 13. Cancer Screening Tests Market Drivers
Table 14. Cancer Screening Tests Market Challenges
Table 15. Cancer Screening Tests Market Restraints
Table 16. Global Cancer Screening Tests Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Cancer Screening Tests Market Share by Players (2019-2024)
Table 18. Global Top Cancer Screening Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Screening Tests as of 2023)
Table 19. Ranking of Global Top Cancer Screening Tests Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Cancer Screening Tests Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cancer Screening Tests Product Solution and Service
Table 23. Date of Enter into Cancer Screening Tests Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Screening Tests Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Cancer Screening Tests Revenue Market Share by Type (2019-2024)
Table 27. Global Cancer Screening Tests Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Cancer Screening Tests Revenue Market Share by Type (2025-2030)
Table 29. Global Cancer Screening Tests Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Cancer Screening Tests Revenue Market Share by Application (2019-2024)
Table 31. Global Cancer Screening Tests Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Cancer Screening Tests Revenue Market Share by Application (2025-2030)
Table 33. North America Cancer Screening Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Cancer Screening Tests Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Cancer Screening Tests Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Cancer Screening Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Cancer Screening Tests Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Cancer Screening Tests Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Cancer Screening Tests Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Cancer Screening Tests Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Cancer Screening Tests Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Cancer Screening Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Cancer Screening Tests Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Cancer Screening Tests Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Cancer Screening Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Cancer Screening Tests Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Cancer Screening Tests Market Size by Country (2025-2030) & (US$ Million)
Table 48. Hologic Company Detail
Table 49. Hologic Business Overview
Table 50. Hologic Cancer Screening Tests Product
Table 51. Hologic Revenue in Cancer Screening Tests Business (2019-2024) & (US$ Million)
Table 52. Hologic Recent Development
Table 53. Siemens Company Detail
Table 54. Siemens Business Overview
Table 55. Siemens Cancer Screening Tests Product
Table 56. Siemens Revenue in Cancer Screening Tests Business (2019-2024) & (US$ Million)
Table 57. Siemens Recent Development
Table 58. GRAIL Company Detail
Table 59. GRAIL Business Overview
Table 60. GRAIL Cancer Screening Tests Product
Table 61. GRAIL Revenue in Cancer Screening Tests Business (2019-2024) & (US$ Million)
Table 62. GRAIL Recent Development
Table 63. Carestream Health Company Detail
Table 64. Carestream Health Business Overview
Table 65. Carestream Health Cancer Screening Tests Product
Table 66. Carestream Health Revenue in Cancer Screening Tests Business (2019-2024) & (US$ Million)
Table 67. Carestream Health Recent Development
Table 68. Philips Company Detail
Table 69. Philips Business Overview
Table 70. Philips Cancer Screening Tests Product
Table 71. Philips Revenue in Cancer Screening Tests Business (2019-2024) & (US$ Million)
Table 72. Philips Recent Development
Table 73. Shimadzu Company Detail
Table 74. Shimadzu Business Overview
Table 75. Shimadzu Cancer Screening Tests Product
Table 76. Shimadzu Revenue in Cancer Screening Tests Business (2019-2024) & (US$ Million)
Table 77. Shimadzu Recent Development
Table 78. Canon Medical Systems Company Detail
Table 79. Canon Medical Systems Business Overview
Table 80. Canon Medical Systems Cancer Screening Tests Product
Table 81. Canon Medical Systems Revenue in Cancer Screening Tests Business (2019-2024) & (US$ Million)
Table 82. Canon Medical Systems Recent Development
Table 83. Hitachi Company Detail
Table 84. Hitachi Business Overview
Table 85. Hitachi Cancer Screening Tests Product
Table 86. Hitachi Revenue in Cancer Screening Tests Business (2019-2024) & (US$ Million)
Table 87. Hitachi Recent Development
Table 88. Esaote Company Detail
Table 89. Esaote Business Overview
Table 90. Esaote Cancer Screening Tests Product
Table 91. Esaote Revenue in Cancer Screening Tests Business (2019-2024) & (US$ Million)
Table 92. Esaote Recent Development
Table 93. Agilent Technologies Company Detail
Table 94. Agilent Technologies Business Overview
Table 95. Agilent Technologies Cancer Screening Tests Product
Table 96. Agilent Technologies Revenue in Cancer Screening Tests Business (2019-2024) & (US$ Million)
Table 97. Agilent Technologies Recent Development
Table 98. Abbott Company Detail
Table 99. Abbott Business Overview
Table 100. Abbott Cancer Screening Tests Product
Table 101. Abbott Revenue in Cancer Screening Tests Business (2019-2024) & (US$ Million)
Table 102. Abbott Recent Development
Table 103. Beckman Coulter Company Detail
Table 104. Beckman Coulter Business Overview
Table 105. Beckman Coulter Cancer Screening Tests Product
Table 106. Beckman Coulter Revenue in Cancer Screening Tests Business (2019-2024) & (US$ Million)
Table 107. Beckman Coulter Recent Development
Table 108. QIAGEN Company Detail
Table 109. QIAGEN Business Overview
Table 110. QIAGEN Cancer Screening Tests Product
Table 111. QIAGEN Revenue in Cancer Screening Tests Business (2019-2024) & (US$ Million)
Table 112. QIAGEN Recent Development
Table 113. R-Biopharm Company Detail
Table 114. R-Biopharm Business Overview
Table 115. R-Biopharm Cancer Screening Tests Product
Table 116. R-Biopharm Revenue in Cancer Screening Tests Business (2019-2024) & (US$ Million)
Table 117. R-Biopharm Recent Development
Table 118. Sysmex Company Detail
Table 119. Sysmex Business Overview
Table 120. Sysmex Cancer Screening Tests Product
Table 121. Sysmex Revenue in Cancer Screening Tests Business (2019-2024) & (US$ Million)
Table 122. Sysmex Recent Development
Table 123. Thrive Early Early Detection Company Detail
Table 124. Thrive Early Early Detection Business Overview
Table 125. Thrive Early Early Detection Cancer Screening Tests Product
Table 126. Thrive Early Early Detection Revenue in Cancer Screening Tests Business (2019-2024) & (US$ Million)
Table 127. Thrive Early Early Detection Recent Development
Table 128. Guardant Health Company Detail
Table 129. Guardant Health Business Overview
Table 130. Guardant Health Cancer Screening Tests Product
Table 131. Guardant Health Revenue in Cancer Screening Tests Business (2019-2024) & (US$ Million)
Table 132. Guardant Health Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Screening Tests Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cancer Screening Tests Market Share by Type: 2023 VS 2030
Figure 3. Physical Exam Features
Figure 4. Imaging Tests Features
Figure 5. Genetic Tests Features
Figure 6. Other Features
Figure 7. Global Cancer Screening Tests Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Cancer Screening Tests Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Lab Case Studies
Figure 12. Other Case Studies
Figure 13. Cancer Screening Tests Report Years Considered
Figure 14. Global Cancer Screening Tests Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Cancer Screening Tests Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Cancer Screening Tests Market Share by Region: 2023 VS 2030
Figure 17. Global Cancer Screening Tests Market Share by Players in 2023
Figure 18. Global Top Cancer Screening Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Screening Tests as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Cancer Screening Tests Revenue in 2023
Figure 20. North America Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Cancer Screening Tests Market Share by Country (2019-2030)
Figure 22. United States Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Cancer Screening Tests Market Share by Country (2019-2030)
Figure 26. Germany Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Cancer Screening Tests Market Share by Region (2019-2030)
Figure 34. China Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Cancer Screening Tests Market Share by Country (2019-2030)
Figure 42. Mexico Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Cancer Screening Tests Market Share by Country (2019-2030)
Figure 46. Turkey Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Cancer Screening Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Hologic Revenue Growth Rate in Cancer Screening Tests Business (2019-2024)
Figure 49. Siemens Revenue Growth Rate in Cancer Screening Tests Business (2019-2024)
Figure 50. GRAIL Revenue Growth Rate in Cancer Screening Tests Business (2019-2024)
Figure 51. Carestream Health Revenue Growth Rate in Cancer Screening Tests Business (2019-2024)
Figure 52. Philips Revenue Growth Rate in Cancer Screening Tests Business (2019-2024)
Figure 53. Shimadzu Revenue Growth Rate in Cancer Screening Tests Business (2019-2024)
Figure 54. Canon Medical Systems Revenue Growth Rate in Cancer Screening Tests Business (2019-2024)
Figure 55. Hitachi Revenue Growth Rate in Cancer Screening Tests Business (2019-2024)
Figure 56. Esaote Revenue Growth Rate in Cancer Screening Tests Business (2019-2024)
Figure 57. Agilent Technologies Revenue Growth Rate in Cancer Screening Tests Business (2019-2024)
Figure 58. Abbott Revenue Growth Rate in Cancer Screening Tests Business (2019-2024)
Figure 59. Beckman Coulter Revenue Growth Rate in Cancer Screening Tests Business (2019-2024)
Figure 60. QIAGEN Revenue Growth Rate in Cancer Screening Tests Business (2019-2024)
Figure 61. R-Biopharm Revenue Growth Rate in Cancer Screening Tests Business (2019-2024)
Figure 62. Sysmex Revenue Growth Rate in Cancer Screening Tests Business (2019-2024)
Figure 63. Thrive Early Early Detection Revenue Growth Rate in Cancer Screening Tests Business (2019-2024)
Figure 64. Guardant Health Revenue Growth Rate in Cancer Screening Tests Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
